CYCLOBENZAPRINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cyclobenzaprine, and when can generic versions of Cyclobenzaprine launch?
Cyclobenzaprine is a drug marketed by Apotex, Macleods Pharms Ltd, Novast Labs, Twi Pharms Inc, Actavis Labs Fl Inc, Aiping Pharm Inc, Aurobindo Pharma, Chartwell Rx, Invagen Pharms, Jubilant Cadista, Kvk Tech, Oxford Pharms, Pliva, Prinston Inc, Rising, Rubicon Research, Sandoz, Sun Pharm Inds Ltd, Tp Anda Holdings, Unichem, and Watson Labs. and is included in twenty-three NDAs.
The generic ingredient in CYCLOBENZAPRINE is cyclobenzaprine hydrochloride. There are sixteen drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. Additional details are available on the cyclobenzaprine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cyclobenzaprine
A generic version of CYCLOBENZAPRINE was approved as cyclobenzaprine hydrochloride by ACTAVIS LABS FL INC on May 3rd, 1989.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CYCLOBENZAPRINE?
- What are the global sales for CYCLOBENZAPRINE?
- What is Average Wholesale Price for CYCLOBENZAPRINE?
Summary for CYCLOBENZAPRINE
| US Patents: | 0 |
| Applicants: | 21 |
| NDAs: | 23 |
| Drug Prices: | Drug price information for CYCLOBENZAPRINE |
| Drug Sales Revenues: | Drug sales revenues for CYCLOBENZAPRINE |
| DailyMed Link: | CYCLOBENZAPRINE at DailyMed |
US Patents and Regulatory Information for CYCLOBENZAPRINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Ltd | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | TABLET;ORAL | 078722-001 | May 12, 2008 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rising | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | TABLET;ORAL | 218936-001 | Sep 12, 2024 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Watson Labs | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | TABLET;ORAL | 073143-001 | Nov 27, 1991 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Tp Anda Holdings | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | TABLET;ORAL | 073541-001 | May 23, 1995 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
